SGN-2FF 纯度: ≥99.0%
SGN-2FF 是一种有效的,具有口服活性的岩藻糖基化抑制剂,抑制岩藻糖基转移酶 (fucosyltransferase) 的活性,具有抗肿瘤活性。
SGN-2FF Chemical Structure
CAS No. : 2089647-47-0
规格 | 价格 | 是否有货 | 数量 |
---|---|---|---|
10 mM * 1 mL in Water | ¥1980 | In-stock | |
5 mg | ¥1800 | In-stock | |
10 mg | ¥2880 | In-stock | |
25 mg | ¥5760 | In-stock | |
50 mg | ¥9200 | In-stock | |
100 mg | ¥14750 | In-stock | |
200 mg | 询价 | ||
500 mg | 询价 |
* Please select Quantity before adding items.
SGN-2FF 相关产品
•相关化合物库:
- Covalent Screening Library Plus
- Clinical Compound Library Plus
- Bioactive Compound Library Plus
- Anti-Cancer Compound Library
- Clinical Compound Library
- Covalent Screening Library
- Anti-Blood Cancer Compound Library
- Targeted Diversity Library
生物活性 |
SGN-2FF is a potent and orally active inhibitor of fucosylation, directly inhibits fucosyltransferase activity. SGN-2FF possesses antitumor activity[1]. |
IC50 & Target |
Fucosyltransferase[1] |
||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
体外研究 (In Vitro) |
SGN-2FF (2-Fluorofucose) is an inhibitor of fucosylation, inhibits cellular fucosylation by depleting the fucosylation substrate GDP-fucose, and by direct inhibition of fucosyltransferases, and leads to the production of afucosylated glycoproteins including antibodies. SGN-2FF activates human T cells in an antigen-dependent manner[1]. MCE has not independently confirmed the accuracy of these methods. They are for reference only. |
||||||||||||||||
体内研究 (In Vivo) |
SGN-2FF exhibits antitumor activity in multiple mouse tumor models, showing substantial tumor growth delay. SGN-2FF elevates the protective effect of a lymphoma vaccine in a syngeneic mouse model[1]. MCE has not independently confirmed the accuracy of these methods. They are for reference only. |
||||||||||||||||
Clinical Trial |
|
||||||||||||||||
分子量 |
166.15 |
||||||||||||||||
Formula |
C6H11FO4 |
||||||||||||||||
CAS 号 |
2089647-47-0 |
||||||||||||||||
运输条件 |
Room temperature in continental US; may vary elsewhere. |
||||||||||||||||
储存方式 |
|
||||||||||||||||
溶解性数据 |
In Vitro:
DMSO : 50 mg/mL (300.93 mM; Need ultrasonic) H2O : 36.67 mg/mL (220.70 mM; Need ultrasonic) 配制储备液
*
请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效。 |
||||||||||||||||
参考文献 |
|
所有产品仅用作科学研究或药证申报,我们不为任何个人用途提供产品和服务